Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.
The treatment of renal limited systemic vasculitis usually involves a combination of cytotoxic drugs and steroids. As shown by randomised prospective controlled trial, plasmapheresis may be of additional benefit for the management of patients with renal involvement severe enough to require dialysis...
Príomhchruthaitheoirí: | Elliott, J, Lockwood, C, Hale, G, Waldmann, H |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
1998
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Monoclonal-antibody therapy in systemic vasculitis.
de réir: Mathieson, P, et al.
Foilsithe / Cruthaithe: (1990) -
MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
de réir: Mathieson, P, et al.
Foilsithe / Cruthaithe: (1990) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
de réir: Lockwood, C, et al.
Foilsithe / Cruthaithe: (1993) -
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
de réir: Lockwood, C, et al.
Foilsithe / Cruthaithe: (1993) -
MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
de réir: Isaacs, J, et al.
Foilsithe / Cruthaithe: (1993)